Basic Information
ID: ALA658492
Type: Functional
Description: Antiviral efficacy measured by a hybrid HIV-l/vaccinia virus infected monkey cell line (HIV- l/vVK-1 infected CV- 1) which produces HIV-1 gag-pol derived polyproteins at 10 uM concentration
Organism: Human immunodeficiency virus 1
Cell type: CV-1
Activity Charts
Bioactivity
Activity Types for Assay ALA658492
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 810.05 | 5.40 | 5.40 |
| 796.03 | 5.39 | 5.39 |
| 711.95 | 4.57 | 4.57 |
| 743.95 | 3.93 | 3.93 |
| 772.99 | 4.30 | 4.30 |
| 758.02 | 6.08 | 6.08 |
| 572.84 | 5.14 | 5.14 |
| 474.69 | 3.55 | 3.55 |
| 516.73 | 3.73 | 3.73 |
| 609.81 | 3.85 | 3.85 |
| 653.82 | 3.30 | 3.30 |
| 574.81 | 5.12 | 5.12 |
| 579.79 | 4.42 | 4.42 |
| 608.82 | 4.79 | 4.79 |
| 532.73 | 2.97 | 2.97 |
| 572.84 | 5.29 | 5.29 |
| 516.73 | 3.73 | 3.73 |
| 812.02 | 4.36 | 4.36 |